ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag survey emulsion pcr funding salary dna sequencing

2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Flow Cytometry On-a-Chip
Jeffrey M. Perkel | Jun 1, 2015 | 7 min read
Novel microfluidic devices give researchers new ways to count and sort single cells.
An Array of Options
Kate Yandell | Jun 1, 2015 | 9 min read
A guide for how and when to transition from the microarray to RNA-seq
Prospecting for Gold in Genome Gulch
Amy Adams | Apr 14, 2002 | 9 min read
The human genome is much like the American West of the 1850s: Everyone wants a piece of the pie. Similar to gold prospectors of 150 years ago, biotech and pharmaceutical companies, and even universities, are frantically searching for the nuggets of gold that will help them find the mother lode—a gene whose function is sufficiently marketable to make all of the preliminary research worthwhile. Companies that do strike gold get to introduce new classes of drugs to the market. Others hope to
Notebook
The Scientist Staff | Sep 1, 1997 | 7 min read
Table of Contents More Newsworthy Sheep Grade Strike Earns an F Brain Drain Sexual Chemistry Cheaper Journals Michign Misconduct Matters Lucky 7 Cloning BRCA2 Credit: Graham G. Ramsay ON THE LAMB: Dario Fauza performed fetal surgery on ovine patients. While Dolly the cloned sheep has yet to disappear from the headlines, other ovines have made medical history. Dario Fauza, a fellow at Harvard Medical School and Children's Hospital in Boston, along with Anthony Atala, an assistant professor of
Legions Of Life Scientists Will Be Called To The Front, As War On AIDS Intensifies
Ricki Lewis | Jun 27, 1993 | 9 min read
With the pandemic mounting and no sure remedies in sight, experts foresee the growing recruitment of skilled researchers On May 21, the World Health Organization announced that 14 million people have been infected with HIV so far, and the global figure could hit 40 million by the year 2000. And the ninth international AIDS meeting in Berlin earlier this month yielded little startling information beyond the general agreement among scientists that they have been, in effect, stymied thus f
Biotech Firm Learns Hard Lessons As Its Founder Seeks To Halt Slide
Sally Lehrman | Jun 24, 1990 | 8 min read
Applied Biosystems finds that as a start-up's glamour fades, it must stress a return to basics FOSTER CITY, CALIF. - The engineer who cofounded Applied Biosystems and made it into a superstar of the biotech instruments industry, only to step back and see it stumble, is back at the helm. And Andre Marion believes that what once worked for the company is also the surest route to its future success. "Success lies in the ability to take chances," says Marion, who returned to hands-on management o

Run a Search

ADVERTISEMENT